LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | R406 | 0.37 | uM | LJP6 | 1 | C16 | 72 | hr | 1476 | 3848 | 3694 | 1.0417 | 1.0694 |
| SK-BR-3 | R406 | 0.37 | uM | LJP6 | 2 | C16 | 72 | hr | 1476 | 3786 | 3694 | 1.0249 | 1.0415 |
| SK-BR-3 | R406 | 0.37 | uM | LJP6 | 3 | C16 | 72 | hr | 1476 | 3844 | 3694 | 1.0406 | 1.0676 |
| SK-BR-3 | Pictilisib | 0.37 | uM | LJP6 | 1 | D22 | 72 | hr | 1476 | 1730 | 3694 | 0.4683 | 0.1142 |
| SK-BR-3 | Pictilisib | 0.37 | uM | LJP6 | 2 | D22 | 72 | hr | 1476 | 1809 | 3694 | 0.4897 | 0.1499 |
| SK-BR-3 | Pictilisib | 0.37 | uM | LJP6 | 3 | D22 | 72 | hr | 1476 | 1949 | 3694 | 0.5276 | 0.2130 |
| SK-BR-3 | Gefitinib | 0.37 | uM | LJP6 | 1 | N10 | 72 | hr | 1476 | 2132 | 3694 | 0.5771 | 0.2955 |
| SK-BR-3 | Gefitinib | 0.37 | uM | LJP6 | 2 | N10 | 72 | hr | 1476 | 2902 | 3694 | 0.7856 | 0.6428 |
| SK-BR-3 | Gefitinib | 0.37 | uM | LJP6 | 3 | N10 | 72 | hr | 1476 | 2616 | 3694 | 0.7082 | 0.5138 |
| SK-BR-3 | Geldanamycin | 0.37 | uM | LJP5 | 1 | O04 | 72 | hr | 1476 | 1554 | 3694 | 0.4207 | 0.0349 |
| SK-BR-3 | Geldanamycin | 0.37 | uM | LJP5 | 2 | O04 | 72 | hr | 1476 | 1424 | 3694 | 0.3855 | -0.0238 |
| SK-BR-3 | Geldanamycin | 0.37 | uM | LJP5 | 3 | O04 | 72 | hr | 1476 | 1364 | 3694 | 0.3692 | -0.0508 |
| SK-BR-3 | Geldanamycin | 0.37 | uM | LJP6 | 1 | O04 | 72 | hr | 1476 | 1277 | 3694 | 0.3457 | -0.0901 |
| SK-BR-3 | Geldanamycin | 0.37 | uM | LJP6 | 2 | O04 | 72 | hr | 1476 | 1376 | 3694 | 0.3725 | -0.0454 |
| SK-BR-3 | Geldanamycin | 0.37 | uM | LJP6 | 3 | O04 | 72 | hr | 1476 | 1274 | 3694 | 0.3449 | -0.0914 |
| SK-BR-3 | GSK1059615 | 0.37 | uM | LJP5 | 1 | E04 | 72 | hr | 1476 | 2882 | 3694 | 0.7802 | 0.6338 |
| SK-BR-3 | GSK1059615 | 0.37 | uM | LJP5 | 2 | E04 | 72 | hr | 1476 | 2718 | 3694 | 0.7358 | 0.5598 |
| SK-BR-3 | GSK1059615 | 0.37 | uM | LJP5 | 3 | E04 | 72 | hr | 1476 | 2429 | 3694 | 0.6575 | 0.4295 |
| SK-BR-3 | GSK1059615 | 0.37 | uM | LJP6 | 1 | C04 | 72 | hr | 1476 | 2186 | 3694 | 0.5918 | 0.3199 |
| SK-BR-3 | GSK1059615 | 0.37 | uM | LJP6 | 2 | C04 | 72 | hr | 1476 | 2349 | 3694 | 0.6359 | 0.3934 |
| SK-BR-3 | GSK1059615 | 0.37 | uM | LJP6 | 3 | C04 | 72 | hr | 1476 | 2322 | 3694 | 0.6286 | 0.3812 |
| SK-BR-3 | GSK1904529A | 0.37 | uM | LJP6 | 1 | H22 | 72 | hr | 1476 | 3246 | 3694 | 0.8787 | 0.7979 |
| SK-BR-3 | GSK1904529A | 0.37 | uM | LJP6 | 2 | H22 | 72 | hr | 1476 | 3662 | 3694 | 0.9913 | 0.9856 |
| SK-BR-3 | GSK1904529A | 0.37 | uM | LJP6 | 3 | H22 | 72 | hr | 1476 | 3883 | 3694 | 1.0511 | 1.0852 |
| SK-BR-3 | Omipalisib | 0.37 | uM | LJP6 | 1 | N04 | 72 | hr | 1476 | 1256 | 3694 | 0.3400 | -0.0995 |